Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Ulrich, L. Taraseviciene, R. Speich, N. Voelkel (Denver, CO, United States Of America; Zurich, Switzerland). RNA expression pattern of peripheral blood B-lymphocytes in idiopathic pulmonary arterial hypertension. Eur Respir J 2007; 30: Suppl. 51, 228

Member's Comments

No comment yet.

Related content which might interest you: Increased regulatory T cells in the blood of patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 659s Year: 2006 Alterations in circulating helper T-cells in idiopathic pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Increased stimulatory capacities of dendritic cells in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension}, Source: Eur Respir J 2012; 40: 895-904 Year: 2012 The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (1) 1701214; 10.1183/13993003.01214-2017 Year: 2018 Towards an understanding of pulmonary arterial hypertension (PAH): gene regulation patterns in pulmonary arterial resistance vessels of patients with PAH Source: Eur Respir J 2006; 28: Suppl. 50, 526s Year: 2006 Multi-omic profiling in pulmonary arterial hypertension Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension Year: 2020 Increased renin-angiotensin-aldosteron system activity in lungs of patients with idiopathic pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension Source: Eur Respir J 2010; 35: 6-8 Year: 2010 Apoptosis and activation of peripheral blood neutrophils in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 74s Year: 2001 Patterns of mean pulmonary artery pressure (mPAP)-flow relation changes following chronic therapy in idiopathic pulmonary arterial hypertension (IPAH) Source: Eur Respir J 2006; 28: Suppl. 50, 427s Year: 2006 Circulating fibrocytes in pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Circulating fibrocytes and pulmonary arterial hypertension Source: Eur Respir J 2011; 39: 210-212 Year: 2012 Circulating fibrocytes and pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 210-212 Year: 2012 Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012 A central role for nuclear factor of activated T cells (NFAT) in human pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Morphological and molecular alterations of pulmonary vasculature in a pig model with increased pulmonary blood flow and pressure compared to "pulmonary plexogenic arteriopathy" (PPA) in children Source: Annual Congress 2007 - Pulmonary hypertension Year: 2007 Histopathology of idiopathic pulmonary arterial hypertension in patients with low or normal diffusion capacity Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012